Angiosarcoma in a soft tissue sarcoma cohort: real-world patterns and outcomes - Top-Institutions - MDSpire

Angiosarcoma in a soft tissue sarcoma cohort: real-world patterns and outcomes

  • By

  • Kübra Canaslan

  • Özge Yetginoğlu

  • Hasan Oğuz Çetinayak

  • Emine Burçin Tuna

  • Tuğba Yavuzşen

  • June 9, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dokuz Eylul University Hospital
    Dokuz Eylul University Hospital

    Izmir, Turkey

    Key Differentiators

    • Oncology

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #4

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #5

    Children’s Oncology Group
    Children’s Oncology Group

    Monrovia, California

    Key Differentiators

    • Oncology

Original Source(s)

Angiosarcoma in a soft tissue sarcoma cohort: real-world patterns and outcomes

  • by Kübra Canaslan, Özge Yetginoğlu, Hasan Oğuz Çetinayak, Emine Burçin Tuna, Tuğba Yavuzşen

  • June 9, 2026

Related Content

Case Report: a rare case of small cell carcinoma of the prostate

Digital Twins as catalysts for Whole Person Health Mind Body Medicine in Integrative Oncology

This Week’s Biopharma News: Big Moves in Bispecifics

Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody

  • June 9, 2026

  • 5 min